Skip to content

Bowel Preparation for Colonoscopy in the Elderly

Bowel Preparation With Standard 4 Liters of PEG vs. Split-dose of 4 Liters PEG vs. Split-dose of 2 Liters PEG Containing Ascorbic Acid Solutions for Outpatient Elective Colonoscopy in the Elderly: A Randomized, Colonoscopist-blinded Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02290093
Enrollment
230
Registered
2014-11-13
Start date
2014-11-30
Completion date
2015-12-31
Last updated
2016-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel Preparation, Colonoscopy

Keywords

Cathartics, Colonoscopy, Polyethylene Glycols, Elderly

Brief summary

The success of colonoscopy is closely related to the quality of colonic preparation. However, data regarding colonoscopy preparations in the elderly (65 years older) are scarce. Split-dosage cathartic bowel preparation are currently suggested, whereas supporting evidence is lacking in this particular group of patients. Moreover, patient tolerability is a key factor for success of bowel preparation in the aged people. The purpose of this study is to compare the bowel cleansing efficacy and patient compliance of following bowel preparation methods prior to elective outpatient colonoscopy in the elderly: (1) standard preparation of 4 liters (L) PEG-3350 solution on the night before colonoscopy, (2) split-dose of 4L PEG-3350 solution, and (3) split-dose of reduced volume \[2L\] PEG-3350 containing ascorbic acid solution.

Interventions

DRUGStandard full-volume PEG

Subjects will be asked to take 4L of PEG-3350 solution the day prior to procedure.

DRUGSplit-dose full-volume PEG

Subjects will be asked to take 2L of PEG-3350 solution the day prior to procedure, followed by another 2L of PEG-3350 solution on the day of the procedure.

DRUGSplit-dose low-volume PEG

Subjects will be asked to take 1L of PEG-3350 containing ascorbic acid solution the day prior to procedure, followed by another 1L of PEG-3350 containing ascorbic acid solution on the day of the procedure.

Sponsors

Kangbuk Samsung Hospital
CollaboratorOTHER
Hanyang University
CollaboratorOTHER
Kyunghee University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* elderly people aged over 65 years * elective outpatient colonoscopy * informed consent

Exclusion criteria

* patients who had bowel movements of less than 3 per week during last one month * patients who have a history of renal dysfunction (abnormal elevation of serum creatinine and electrolyte imbalance) * patients who have a history of alimentary tract surgery * patients who have other gastrointestinal diseases that are not suitable for undergoing colonoscopy (gastroparesis, gastric outlet obstruction, ileus, ischemic colitis, megacolon, and toxic colitis) * patients classified as the American Society for Anesthesiology class III or higher * Any condition which, in the opinion of the Investigator, places the patient at unacceptable risk if he/she were to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Proportion of adequate bowel preparation quality at the time of colonoscopy defined by the Boston bowel preparation scale (BBPS).1 yearThe BBPS assesses cleanliness of 3 segments of the colon (ascending, transverse, and descending colon), and the total is a 10-point scale (0-9) that grades each segment of the colon from 0 to 3. In this study, adequate bowel preparation is defined as a total score 6 points or higher and individual score of 2 points or higher in each segment.

Secondary

MeasureTime frameDescription
Rate of adverse events related to bowel preparation for colonoscopy1 yearAdverse events include tenesmus, sleep disturbance, nausea, vomiting, abdominal cramping, abdominal fullness, abdominal discomfort, headache, dizziness, and others.
Number of patients who have a willingness to repeat same bowel preparation method method1 year
Patient satisfaction with recommended bowel preparation method based on the 10-point visual analog scale1 year
Difficulty of completing ingestion of recommended bowel preparation agent based on the 3-grade scale1 yearThe 3-grade scale: never, some, and much
Taste of recommended bowel preparation agent based on the 3-grade scale1 yearThe 3-grade scale: bad, neutral, and good
Consumed volume of recommended bowel preparation agent based on the 3-grade scale1 yearThe 3-grade scale: optimal (100%), good (≥ 75%), and poor (\< 75%)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026